Schizophrenia Clinical Trial
Official title:
Promoting Health and Functioning in Persons With SMI
Few studies targeting obesity in serious mental illness have reported clinically significant risk reduction, and non have been replicated in community settings or demonstrated sustained outcomes after intervention withdrawal. The researchers sought to replicate positive health outcomes demonstrated in a previous randomized effectiveness study of the In SHAPE program across urban community mental health organizations serving an ethnically diverse population.
Status | Completed |
Enrollment | 133 |
Est. completion date | August 2009 |
Est. primary completion date | August 2009 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 21 Years and older |
Eligibility |
Inclusion Criteria: - Age 21 or older - Serious mental illness defined by an axis I diagnosis of major depression, bipolar disorder, schizoaffective disorder, or schizophrenia - Persistent impairment in multiple areas of functioning (e.g., work, school, self-care) - Body mass index (BMI) greater than 25 - Able and willing to provide informed consent - On stable pharmacological treatment (same psychiatric medications over prior 2 months) Exclusion Criteria: - Residing in a nursing home of other institution - Diagnosis of dementia or significant cognitive impairment (MMSE<24) - Unable to walk one city block - Pregnant or planning to become pregnant within the next 18 months - Unable to speak English - Terminal illness with life expectancy <1 year - Current diagnosis of an active substance dependence disorder |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
United States | Riverbend Community Mental Health | Concord | New Hampshire |
Lead Sponsor | Collaborator |
---|---|
Dartmouth-Hitchcock Medical Center |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Exercise Capacity | Change in fitness as measured by the 6-minute walk test. | Baseline, 3-, 6-, 9-, and 12-months | No |
Secondary | Body Mass Index | Baseline, 3-, 6-, 9-, and 12-months | No | |
Secondary | Change in Weight | Change in weight over time was measured at baseline, 3-, 6-, 9-, and 12-months. Measures were weight (lbs). | Baseline, 3-, 6-, 9-, and 12-months | No |
Secondary | Change in Triglycerides and Cholesterol | Change in triglycerides and cholesterol measured with the CardioChek PA Analyzer: Fasting blood glucose and lipids. | Baseline, 3-, 6-, 9-, and 12-months | No |
Secondary | Change in Health Status | Change in health status was measured by the SF-12: Medical Outcomes Study Short Form -12 | Baseline, 3-, 6-, 9-, and 12-months | No |
Secondary | Change in Community Functioning | Change in community functioning was measured by the ILSS: Independent Living Skills Scale | Baseline, 9-, and 12-months | No |
Secondary | Change in Physical Measurements (Fitness) | Change is physical measurements was determined by measuring waist circumference and resting pulse | Baseline, 3-, 6-, 9-, and 12-months | No |
Secondary | Change in Psychological State | Change in psychological state was measured using the CESD: Cntr Epid Studies Dep; SANS: Scale Assess Neg Sx; R-SES: Revised Self-efficacy Scale | Baseline, 3-, 6-, 9-, and 12-months | No |
Secondary | Change in Participation in Exercise | Change in participation in exercise was determined by measuring weekly exercise at 3-, 6-, 9-, and 12-months using a physical activity log; weekly health club attendance at 3-, 6-, 9-, and 12-months based on frequency of YMCA visits; total physical activity at baseline, 3-, 6-, 9-, and 12-months based on the YPAS: Yale Physical Activity Scale. | Baseline, 3-, 6-, 9-, and 12-months | No |
Secondary | Change in Diet Behaviors | Change in diet behaviors was measured based on the WLB-SOC: Weight Loss Behavior State of Change Scale. | Baseline, 3-, 6-, 9-, and 12-months | No |
Secondary | Change in Preventative Health Care | Change in preventative health care was based on the PHC: Preventative Healthcare Checklist | Baseline and 12-months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |